Tumor Ablation Market Is Predicted To Reach USD 1.5 Billion By 2022:By Grand View Research, Inc.
Global tumor ablation market is expected to reach USD 1.5
billion by 2022, according to a new study by Grand View Research Inc. Rising
prevalence of different forms of cancer and increasing technological
advancements in the field of thermal ablation techniques are the most prominent
drivers of the market.
Besides the use of thermal ablation, techniques such as
laser ablation, irreversible electroporation, High Intensity Focused
Ultrasonography (HIFU) are also clinically growing, concurrently propelling the
tumor ablation industry.
Occurrence of lung, breast, and liver cancer is on the rise
globally. According to the Center for Disease Control (CDC) and other
organizations, currently, about 210,828 cases of lung cancer, 2.9 million cases
of breast cancer, and over 2.7 million cases of prostate cancer are reported in
the U.S. alone.
In terms of technological advancement, companies such as
SonaCare Medical are coupling ablation techniques with other technologies to
improve accuracy, performance, and level of care. SonaLink, a remote patient
monitoring platform, was put to use along with Sonatherm ablation system to
enable physicians to enhance patient care experience, thereby promoting market
growth.
The industry is also anticipated to witness mergers and
joint collaborations as a tool to curb rising competition. For instance, Boston
Scientific Corporation acquired C.R. Bard Electrophysiology, which led to a
48.0% hike in profit for the former company.
Browse full research report on Tumor
Ablation Market http://www.grandviewresearch.com/industry-analysis/tumor-ablation-market
Further key findings from the study suggest:
- Microwave
ablation technology is expected to be the fastest growing segment over the
forecast period at a CAGR of over 15.0%. Reduction in the procedure time
and low cost for treatment are some of the attributes favoring growth.
- In
terms of treatment, surgical ablation is predicted to form the largest
market by 2022 with about 35.0% share. Liver and lung cancer ablation
require surgical procedures, and since these form the largest and fastest
growing segments, they concomitantly propel surgical ablation growth.
- Lung
cancer forms the most lucrative market and is anticipated to be the
fastest growing segment over the forecast period. By 2022, it is expected
to contribute about 15.0% of the revenue share owing to its rising
prevalence rate across the globe.
- According
to market forecast for 2022, North America is expected to dominate the
market and Asia Pacific is anticipated to witness the fastest growth.
Augmenting growth in the cancer prevalence and rising healthcare
expenditure in regions such as China, Korea, and India are factors
responsible for this rapid growth.
- Major
players of the market include HealthTronics, Galil Medical Inc.,
Angiodynamics, Medtronic Plc. (Covidien), Boston Scientific Corporation,
SonaCare Medical, Misonix Inc., EDAP TMS S.A., and Neuwave Medical Inc. To
retain market leadership, players such as Medtronic are working towards
acquiring other companies and expanding their portfolio. For instance, in
January 2016, Medtronic acquired the OsteoCool RF Ablation System from
Baylis Medical.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global tumor ablation
market on the basis of technology, treatment, application, and region
Global Tumor Ablation Technology Outlook (USD million),
2012 - 2022
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
Global Tumor Ablation Treatment Outlook (USD million),
2012 - 2022
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
tumor ablation
Global Tumor Ablation Application Outlook (USD million),
2012 - 2022
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancers
Tumor Ablation Region Outlook (USD million), 2012 - 2022
- North
America
- U.S.
- U.S.
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- U.S.
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- U.S.
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Canada
- Canada
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Canada
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Canada
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Europe
- UK
- UK
tumor ablation market technology outlookUK tumor ablation market
treatment outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- UK
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Germany
- Germany
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Germany
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Germany
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Asia
Pacific
- Japan
- Japan
tumor ablation market technology outlook Japan tumor ablation
market treatment outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Japan
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- China
- China
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- China
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- China
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Latin
America
- Brazil
- Brazil
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Brazil
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Brazil
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Mexico
- Mexico
tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Mexico
tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Mexico
tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- MEA
- South
Africa
- South
Africa tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- South
Africa tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- South
Africa tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
- Saudi
Arabia
- Saudi
Arabia tumor ablation market technology outlook
- Radiofrequency
- Microwave
ablation
- Cryoablation
- Other
ablation technologies
- Saudi
Arabia tumor ablation market treatment outlook
- Surgical
tumor ablation
- Laparoscopic
tumor ablation
- Percutaneous
- Saudi
Arabia tumor ablation market application outlook
- Liver
cancer
- Breast
cancer
- Lung
cancer
- Prostate
cancer
- Other
cancer
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/global-tumor-ablation-market
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com
Comments
Post a Comment